| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |